US Stock MarketDetailed Quotes
LGVN Longeveron
- 1.750
- +0.080+4.79%
Close Apr 26 16:00 ET
- 1.710
- -0.040-2.29%
Post 18:38 ET
8.40MMarket Cap-171P/E (TTM)
1.790High1.620Low373.38KVolume1.670Open1.670Pre Close641.56KTurnover13.49%Turnover RatioLossP/E (Static)4.80MShares44.00052wk High1.25P/B4.85MFloat Cap1.60052wk Low--Dividend TTM2.77MShs Float450.000Historical High--Div YieldTTM10.16%Amplitude1.600Historical Low1.718Avg Price1Lot Size
Longeveron Stock Forum
Sign in to post a comment
Update! Worth it! Hehehe
$Longeveron(LGVN.US$ Longeveron Raises a Total of $11.4 Million in Gross Proceeds From Warrant Exercise Offering and Public Offering
2
$Longeveron(LGVN.US$
NEWS
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering
NEWS
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering
1
$Longeveron(LGVN.US$ Dark orders...be careful if you are trying to short this.
1
$Longeveron (LGVN.US)$ This hit 4.25 yesterday, and I can assure you that Wainwright isn't taking any losses here. They know the deal! Expect a low of 2.50, and this bounces back to over 3.50 once Wainwright takes the reigns. This is a 15.00+ stock.
1
Update
$Longeveron(LGVN.US$ Longeveron Announces Exercise Of Warrants For $6.2M Gross Proceeds
Benzinga· 3 mins ago
Benzinga· 3 mins ago
6
$Longeveron(LGVN.US$
BUYERS ARE NO POWER OR WHAT 🤔
BUYERS ARE NO POWER OR WHAT 🤔
1
Medical Research Company Announces Alzheimer's Treatment Trial Spotlight
Groundbreaking Alzheimer's Treatment Trial by Longeveron to Be Spotlighted at AAIC 2024.
In an unprecedented move that could herald a new era in the battle against Alzheimer's disease, Longeveron Inc., a trailblazer in the field of regenerative medicine, has announced its CLEAR MIND Phase 2a clinical trial focusing on Lomecel-B™ for mild Alzheimer’s Disease will be featured at the 2024 Alzheimer's Association International C...
In an unprecedented move that could herald a new era in the battle against Alzheimer's disease, Longeveron Inc., a trailblazer in the field of regenerative medicine, has announced its CLEAR MIND Phase 2a clinical trial focusing on Lomecel-B™ for mild Alzheimer’s Disease will be featured at the 2024 Alzheimer's Association International C...
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
帥帥 : Is it a good buy?
TrytosaveabitOP 帥帥: In my opinion? I think it is a good ticker for a swing trade! JMO NFA!